Cited by 7Obsessive-Compulsive Spectrum DisordersAutism Spectrum Disorder ResearchSchizophrenia research and treatment

Obsessive-Compulsive, Psychotic, and Autism Dimensions Overlap in Real World: A Case Report

Open access
Scala, Mauro, Biondi, Laura, Serretti, Alessandro, Fabbri, Chiara·2023·Clinical Neuropharmacology

Abstract

Background: Obsessions, compulsions, and stereotypes are common psychopathological manifestations of obsessive-compulsive, psychotic, and autism spectrum disorders (ASDs). These nosological entities may be present in comorbidity, with relevant clinical difficulties in the differential diagnosis process. Moreover, ASDs are a complex group of disorders, with a childhood onset, which also persist into adulthood and present heterogeneous symptom patterns that could be confused with psychotic disorders. Methods and Results: We report a case of a 21-year-old man characterized by sexual and doubt obsessions; disorganized, bizarre, and stereotyped behaviors and compulsions; and social withdrawal, inadequate social skills, visual dispersions, and hypersensitivity to light stimuli. Obsessive and compulsive features were initially included within the differential diagnosis of psychotic and obsessive-compulsive spectrum disorders. However, aforementioned psychopathological elements did not improve when multiple antipsychotic drugs (olanzapine, haloperidol, and lurasidone) were administered in the hypothesis of schizophrenia and even worsened with clozapine therapy at a dose of 100 mg/d. Obsessions and compulsions progressively reduced during the fluvoxamine 14-week treatment paradigm at a dose of 200 mg/d. Considering the persistent deficits in social communication and interactions as well as the restricted interests pattern, a differential diagnostic hypothesis of ASD was formulated, and it was then confirmed at the final evaluation at a third-level health care center. Conclusions: We discuss similarities and differences in the psychopathology of obsessions, compulsions, and stereotypes in the previously mentioned disorders, to underline factors that can help in the differential diagnosis of similar cases, and consequently in the appropriateness of treatment choice.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/wnf.0000000000000561

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Obsessive and compulsive-like symptoms in ASD differ from those in OCD and present unique psychopathological experiences.

    “though obsessive and compulsive-like symptoms in ASD differ from those in OCD and present unique psychopathological experiences. 106”

    From The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges (2024) · cites this paper as [106]

    The Abstract > Conclusions says the nature of obsessions and repetitive behaviors in ASD versus OCD is debated, and that the case illustrates similarities and differences in their psychopathology. The Discussion describes the patient's distinctive response to repetitive behaviors, but the paper does not establish as a general fact that these symptoms differ in all people with ASD or constitute unique psychopathological experiences. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • Psilocybin may be useful in reducing pervasive interests and repetitive behaviors in ASD.

    “it may also be useful in reducing the pervasive interests and repetitive behaviors in ASD”

    From The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges (2024) · cites this paper as [106]

    The Discussion reports reduced obsessions and ritualistic behaviors after fluvoxamine treatment in one patient with ASD, but it does not discuss psilocybin. A search of our copy for psilocybin and psychedelic treatment found no passage addressing whether psilocybin may reduce pervasive interests or repetitive behaviors in ASD. No page numbers were supplied for the indexed passages. (LLM, conf=0.78)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 40 · Cited by 7

Research works printed but not linked: 2

  1. [3]Jablensky A. The epidemiological horizon. In: Schizophrenia. Oxford, United Kingdom: Blackwell Science Ltd: 203– 231.
  2. [13]Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition, Text Revision ed. Washington, DC: American Psychiatric Association; 2022.

Authors
Scala, M., Biondi, L., Serretti, A., & Fabbri, C.
Affiliations
  • University of Bologna (IT)
  • King's College London (GB)
Corresponding author
  • Scala, Mauro
  • Biondi, Laura
  • Serretti, Alessandro
  • Fabbri, Chiara
Venue
Clinical Neuropharmacology
Published
2023-06-21
Volume
46
Issue
4
Pages
149-152
ISSN
  • 0362-5664 (ISSN-L)
  • 1537-162X
OpenAlex
W4382182236
Cited by
7
References
40
Citations by year
2025: 2 · 2024: 4 · 2023: 1
FWCI
2.03
Type
journal article
Language
en
Open access
Locations
  • Clinical Neuropharmacology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
obsessive-compulsive disorder, autism spectrum disorder, psychosis, comorbidities, obsession, compulsive behavior, stereotypy, differential diagnosis, fluvoxamine, antipsychotic drugs, clozapine adverse effects, social withdrawal, restricted interests

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review